MELKART DUO 50MG/1000MG Potahovaná tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

melkart duo 50mg/1000mg potahovaná tableta

g.l. pharma gmbh, lannach array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/1000mg - metformin a vildagliptin

MELKART DUO 50MG/850MG Potahovaná tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

melkart duo 50mg/850mg potahovaná tableta

g.l. pharma gmbh, lannach array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a vildagliptin

TUTECVI COMBI 50MG/1000MG Potahovaná tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

tutecvi combi 50mg/1000mg potahovaná tableta

viatris limited, dublin array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/1000mg - metformin a vildagliptin

TUTECVI COMBI 50MG/850MG Potahovaná tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

tutecvi combi 50mg/850mg potahovaná tableta

viatris limited, dublin array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a vildagliptin

Eucreas Evropská unie - čeština - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) Evropská unie - čeština - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).

Zomarist Evropská unie - čeština - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformin hydrochloridu - diabetes mellitus, typ 2 - léky užívané při diabetu - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Vildagliptin / Metformin hydrochloride Accord Evropská unie - čeština - EMA (European Medicines Agency)

vildagliptin / metformin hydrochloride accord

accord healthcare s.l.u. - metformin hydrochloride, vildagliptin - diabetes mellitus, typ 2 - léky užívané při diabetu - vildagliptin/metformin hydrochloride accord is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:- in patients who are inadequately controlled with metformin hydrochloride alone. - in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. - in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 a 5. 1 pro dostupné údaje o různých kombinacích).

AGNIS COMBI 50MG/1000MG Potahovaná tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

agnis combi 50mg/1000mg potahovaná tableta

belupo lijekovi i kozmetika, d.d., koprivnica array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/1000mg - metformin a vildagliptin

AGNIS COMBI 50MG/850MG Potahovaná tableta Česká republika - čeština - SUKL (Státní ústav pro kontrolu léčiv)

agnis combi 50mg/850mg potahovaná tableta

belupo lijekovi i kozmetika, d.d., koprivnica array - 17128 vildagliptin; 2418 metformin-hydrochlorid - potahovaná tableta - 50mg/850mg - metformin a vildagliptin